| Primary |
| Hypertension |
62.8% |
| Diabetes Mellitus |
4.9% |
| Blood Cholesterol Increased |
4.8% |
| Prophylaxis |
2.9% |
| Pain |
2.6% |
| Blood Pressure Increased |
2.5% |
| Essential Hypertension |
2.5% |
| Blood Pressure |
2.3% |
| Device Related Infection |
1.8% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Hypothyroidism |
1.6% |
| Asthma |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Depression |
1.4% |
| Cardiac Disorder |
1.1% |
| Osteoporosis |
1.1% |
| Arthritis |
1.0% |
| Back Pain |
1.0% |
| Drug Use For Unknown Indication |
0.7% |
| Blood Cholesterol |
0.6% |
|
| Blood Pressure Increased |
9.6% |
| Rash |
9.6% |
| Drug Ineffective |
7.5% |
| Dizziness |
6.3% |
| Vomiting |
5.9% |
| Hypertension |
5.4% |
| Hypertensive Crisis |
5.0% |
| Weight Decreased |
5.0% |
| Hyponatraemia |
4.6% |
| Vision Blurred |
4.6% |
| Weight Increased |
4.6% |
| Pollakiuria |
4.2% |
| Renal Failure Acute |
4.2% |
| Alopecia |
3.8% |
| Hypotension |
3.8% |
| Tinnitus |
3.8% |
| Myocardial Infarction |
3.3% |
| Blood Pressure Inadequately Controlled |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Death |
2.9% |
|
| Secondary |
| Hypertension |
54.7% |
| Diabetes Mellitus |
7.1% |
| Gastrooesophageal Reflux Disease |
4.8% |
| Chronic Obstructive Pulmonary Disease |
4.3% |
| Atrial Fibrillation |
2.8% |
| Blood Cholesterol Increased |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Asthma |
2.6% |
| Hyperlipidaemia |
2.0% |
| Arthritis |
1.7% |
| Cardiac Disorder |
1.7% |
| Prophylaxis |
1.7% |
| Blood Pressure |
1.4% |
| Depression |
1.4% |
| Essential Hypertension |
1.4% |
| Hypothyroidism |
1.4% |
| Neuralgia |
1.4% |
| Pain |
1.4% |
| Acute Coronary Syndrome |
1.1% |
| Back Pain |
1.1% |
|
| Renal Failure Acute |
14.9% |
| Dyspnoea |
7.5% |
| Hypertensive Crisis |
6.0% |
| Hypotension |
6.0% |
| Muscle Spasms |
6.0% |
| Thrombocytopenia |
6.0% |
| Hypertension |
4.5% |
| Hyponatraemia |
4.5% |
| Myocardial Infarction |
4.5% |
| Oedema Peripheral |
4.5% |
| Palpitations |
4.5% |
| Tremor |
4.5% |
| Vomiting |
4.5% |
| Weight Increased |
4.5% |
| Alopecia |
3.0% |
| Blood Pressure Inadequately Controlled |
3.0% |
| Blood Pressure Increased |
3.0% |
| Coma |
3.0% |
| Dizziness |
3.0% |
| Drug Ineffective |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.7% |
| Hypertension |
21.4% |
| Drug Use For Unknown Indication |
11.8% |
| Diabetes Mellitus |
5.2% |
| Rheumatoid Arthritis |
4.5% |
| Type 2 Diabetes Mellitus |
4.1% |
| Pain |
3.6% |
| Prophylaxis |
3.4% |
| Blood Cholesterol Increased |
2.5% |
| Atrial Fibrillation |
2.4% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Osteoporosis |
1.8% |
| Depression |
1.6% |
| Osteoarthritis |
1.4% |
| Carcinoid Tumour Pulmonary |
1.3% |
| Diffuse Large B-cell Lymphoma |
1.3% |
| Renal Cell Carcinoma |
1.3% |
| Back Pain |
1.2% |
| Hypersensitivity |
1.1% |
| Metastatic Renal Cell Carcinoma |
1.1% |
|
| Weight Decreased |
14.9% |
| Myocardial Infarction |
6.8% |
| Pulmonary Embolism |
6.4% |
| Vomiting |
6.4% |
| Syncope |
5.5% |
| Dizziness |
5.1% |
| Nausea |
5.1% |
| Pneumonia |
5.1% |
| Urinary Tract Infection |
5.1% |
| Paraesthesia |
4.3% |
| Pruritus |
4.3% |
| Weight Increased |
4.3% |
| Hypertension |
3.8% |
| Cerebrovascular Accident |
3.4% |
| Death |
3.4% |
| Interstitial Lung Disease |
3.4% |
| Pain |
3.4% |
| Vertigo |
3.4% |
| Blood Glucose Increased |
3.0% |
| Fatigue |
3.0% |
|
| Interacting |
| Hypertension |
37.5% |
| Ischaemic Cardiomyopathy |
18.8% |
| Thrombosis Prophylaxis |
18.8% |
| Cardiovascular Event Prophylaxis |
12.5% |
| Hyperuricaemia |
6.3% |
| Type 2 Diabetes Mellitus |
6.3% |
|
| Renal Failure Acute |
75.0% |
| Hypotension |
25.0% |
|
